Affiliates of private equity firm Altus Capital Partners agreed to pay $11.03 per share for MGC Diagnostics, which makes equipment that monitor's a person's heart rate and breathing. MGC Diagnostics ...
St. Paul's MGC Diagnostics will buy Belgium-based Medisoft, which also makes systems for detecting heart and lung disease, in a deal it called "mission critical." A Minnesota maker of systems for ...
St. Paul-based MGC Diagnostics, which makes equipment for diagnosing asthma and lung disease, announced the completion of its acquisition by the private equity firm Altus Capital Partners Inc at $50.3 ...
MGC Diagnostics Corporation, formerly known as Angeion Corporation, has sold assets of its New Leaf business to Chanhassen-based Life Time Fitness, Inc. Under the terms of the deal, Life Time paid ...
MGC, which is backed by Altus Capital Partners, has acquired Lemon Medical, a German medical tech company. No financial terms were disclosed. SAINT PAUL, Minn.–(BUSINESS WIRE)–MGC Diagnostics ...
MGC Diagnostics will be a more proactive, forward-looking organization with a renewed dedication to product innovation, unmatched customer service and support, and always anticipating and creating ...
ST. PAUL, Minn., Aug. 21, 2012 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, is pleased to announce its new trading symbol is effective today, August ...
SAINT PAUL, Minn.--(BUSINESS WIRE)--MGC Diagnostics Corporation (“MGC”), a global medical technology company dedicated to cardiorespiratory health solutions, and a portfolio company of Altus Capital ...
Good afternoon and welcome to the MGC Diagnostics’ Third Quarter Fiscal Year 2017 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s ...
Thank you. Thank you for joining us to review the financial results of MGC Diagnostics Corporation for the first quarter of fiscal year 2014, which ended January 31, 2014. As Denise indicated, my name ...
Altus Capital Partners is acquiring MGC Diagnostics Corp., a publicly traded medical technology company that focuses on cardiorespiratory health, for about $50.3 million. MGC Diagnostics in a press ...
ACT NOW: Monteverde & Associates PC Announces An Investigation Of MGC Diagnostics Corporation - MGCD
NEW YORK, NY / ACCESSWIRE / December 5, 2017 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results